Zurich Insurance Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.02M | Hold |
9,000
| – | – | 0.02% | 279 |
|
|
2025
Q4 | $2.17M | Hold |
9,000
| – | – | 0.02% | 232 |
|
|
2025
Q3 | $2.46M | Hold |
9,000
| – | – | 0.02% | 184 |
|
|
2025
Q2 | $2.32M | Hold |
9,000
| – | – | 0.02% | 177 |
|
|
2025
Q1 | $2.01M | Sell |
9,000
-329,029
| -97% | -$76.8M | 0.02% | 183 |
|
|
2024
Q4 | $77.3M | Sell |
338,029
-44,043
| -12% | -$10.6M | 0.63% | 41 |
|
|
2024
Q3 | $93.3M | Sell |
382,072
-22,867
| -6% | -$5.11M | 0.79% | 32 |
|
|
2024
Q2 | $77.5M | Sell |
404,939
-24,987
| -6% | -$5.07M | 0.67% | 48 |
|
|
2024
Q1 | $85.1M | Sell |
429,926
-139,482
| -24% | -$25.6M | 0.78% | 40 |
|
|
2023
Q4 | $97.9M | Buy |
569,408
+457,308
| +408% | +$70.3M | 1% | 24 |
|
|
2023
Q3 | $16.6M | Buy |
112,100
+105,700
| +1,652% | +$19.1M | 0.18% | 112 |
|
|
2023
Q2 | $1.4M | Hold |
6,400
| – | – | 0.01% | 181 |
|
|
2023
Q1 | $1.4M | Hold |
6,400
| – | – | 0.02% | 181 |
|
|
2022
Q4 | $1.33M | Sell |
6,400
-243,473
| -97% | -$53.5M | 0.02% | 162 |
|
|
2022
Q3 | $54.5M | Buy |
249,873
+14,532
| +6% | +$3.31M | 0.85% | 39 |
|
|
2022
Q2 | $49.3M | Buy |
235,341
+36,210
| +18% | +$7.71M | 0.73% | 42 |
|
|
2022
Q1 | $48.3M | Buy |
+199,131
| New | +$48.2M | 0.6% | 56 |
|
|
2021
Q1 | – | Sell |
-82,569
| Closed | -$17.6M | – | 224 |
|
|
2020
Q4 | $17.6M | Sell |
82,569
-328,364
| -80% | -$65.5M | 0.26% | 58 |
|
|
2020
Q3 | $70.4M | Sell |
410,933
-39,256
| -9% | -$7.25M | 1.22% | 31 |
|
|
2020
Q2 | $86.4M | Buy |
450,189
+89,007
| +25% | +$14.6M | 1.47% | 25 |
|
|
2020
Q1 | $53.2M | Buy |
361,182
+186,769
| +107% | +$29.7M | 1.14% | 28 |
|
|
2019
Q4 | $27M | Buy |
174,413
+151,126
| +649% | +$21.8M | 0.49% | 64 |
|
|
2019
Q3 | $3.15M | Buy |
23,287
+771
| +3% | +$101K | 0.06% | 312 |
|
|
2019
Q2 | $2.75M | Buy |
22,516
+882
| +4% | +$97.7K | 0.05% | 299 |
|
|
2019
Q1 | $2.25M | Buy |
21,634
+107
| +0.5% | +$11K | 0.05% | 271 |
|
|
2018
Q4 | $2.45M | Sell |
21,527
-44,242
| -67% | -$4.74M | 0.06% | 240 |
|
|
2018
Q3 | $7.59M | Sell |
65,769
-1
| -0% | -$110 | 0.16% | 170 |
|
|
2018
Q2 | $6.81M | Buy |
65,770
+36,269
| +123% | +$3.67M | 0.15% | 192 |
|
|
2018
Q1 | $2.9M | Buy |
29,501
+9,343
| +46% | +$883K | 0.07% | 339 |
|
|
2017
Q4 | $1.71M | Buy |
20,158
+9,958
| +98% | +$823K | 0.04% | 444 |
|
|
2017
Q3 | $785K | Sell |
10,200
-539
| -5% | -$41.2K | 0.02% | 574 |
|
|
2017
Q2 | $836K | Sell |
10,739
-7,237
| -40% | -$518K | 0.02% | 530 |
|
|
2017
Q1 | $1.29M | Buy |
+17,976
| New | +$1.24M | 0.04% | 422 |
|
Other funds holding RMD
VCM
VPM
DAM
Zurich Insurance Group's RMD Position: Q1 2026 in Review
Zurich Insurance Group held its ResMed (RMD) position steady in Q1 2026 at 9,000 shares worth $2.02M. The position accounts for 0.02% of the portfolio, ranked #279.
Zurich Insurance Group first reported a position in RMD in Q1 2017 and has held it in 33 quarters since. The position peaked at $97.9M in Q4 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Zurich Insurance Group held 9,000 shares of ResMed worth $2.02M as of Q1 2026.
- Zurich Insurance Group left its ResMed share count unchanged in Q1 2026.
- ResMed made up 0.02% of Zurich Insurance Group's portfolio in Q1 2026, its #279 holding.
- Zurich Insurance Group first reported a position in ResMed in Q1 2017 and has held it in 33 quarters since.
- Zurich Insurance Group's ResMed position peaked at $97.9M in Q4 2023.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.